XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Accounting Policies [Abstract] |
Schedules of Concentration of Risks | The following table represents receivables from our customers exceeding 10% of our total receivables, excluding receivables held for sale:
Customer | September 30, 2023 |  | December 31, 2022
Customer A | * |  | 31 | %
The following table represents revenue from our customers exceeding 10% of our total revenue, excluding revenues from discontinued operations:
| Three Months Ended September 30, | Nine Months Ended September 30,
Customer | 2023 |  | 2022 |  | 2023 |  | 2022
Customer A | 16 | % |  | 12 | % |  | 16 | % |  | 11 | %
Schedule of Condensed Consolidated Financial Statements Impacts Resulting from Restatement | The tables below set forth the condensed consolidated financial statements, including as reported, the impacts resulting from the restatement and the as restated amounts for the quarterly period ended September 30, 2023 (in thousands, except per share amounts):
| Condensed Consolidated Statement of Operations
For the three months ended September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Cost of sales | $ | (10,909) |  |  | $ | 1,015 |  |  | $ | (9,894) |
Impairments | (7,674) |  |  | 7,282 |  |  | (392) |
Total operating expense | (44,618) |  |  | 8,297 |  |  | (36,321) |
Operating loss | (11,336) |  |  | 8,297 |  |  | (3,039) |
Loss from continuing operations before income taxes | (17,835) |  |  | 8,297 |  |  | (9,538) |
Benefit from income taxes | 1,442 |  |  | (388) |  |  | 1,054 |
Net loss from continuing operations | (16,393) |  |  | 7,909 |  |  | (8,484) |
Net loss | (15,074) |  |  | 7,909 |  |  | (7,165) |
Net loss attributable to PLBY Group, Inc. | (15,074) |  |  | 7,909 |  |  | (7,165) |
Net loss per share from continuing operations, basic and diluted | (0.22) |  |  | 0.10 |  |  | (0.12) |
Net loss per share, basic and diluted | (0.20) |  |  | 0.10 |  |  | (0.10) |
| Condensed Consolidated Statement of Operations
For the nine months ended September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Cost of sales | $ | (43,545) |  |  | $ | 2,215 |  |  | $ | (41,330) |
Impairments | (155,864) |  |  | 9,232 |  |  | (146,632) |
Total operating expense | (299,107) |  |  | 11,447 |  |  | (287,660) |
Operating loss | (195,521) |  |  | 11,447 |  |  | (184,074) |
Loss from continuing operations before income taxes | (199,848) |  |  | 11,447 |  |  | (188,401) |
Benefit from income taxes | 13,062 |  |  | (1,470) |  |  | 11,592 |
Net loss from continuing operations | (186,786) |  |  | 9,977 |  |  | (176,809) |
Net loss | (186,637) |  |  | 9,977 |  |  | (176,660) |
Net loss attributable to PLBY Group, Inc. | (186,637) |  |  | 9,977 |  |  | (176,660) |
Net loss per share from continuing operations, basic and diluted | (2.65) |  |  | 0.15 |  |  | (2.50) |
Net loss per share, basic and diluted | (2.65) |  |  | 0.15 |  |  | (2.50) |
| Condensed Consolidated Statement of Comprehensive Loss
For the three months ended September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Net loss | $ | (15,074) |  |  | $ | 7,909 |  |  | $ | (7,165) |
Comprehensive loss | (16,256) |  |  | 7,909 |  |  | (8,347) |
| Condensed Consolidated Statement of Comprehensive Loss
For the nine months ended September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Net loss | $ | (186,637) |  |  | $ | 9,977 |  |  | $ | (176,660) |
Comprehensive loss | (189,787) |  |  | 9,977 |  |  | (179,810) |
| Condensed Consolidated Balance Sheet
As of September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Deferred revenues, net of current portion | $ | 22,580 |  |  | $ | (11,447) |  |  | $ | 11,133 |
Deferred tax liabilities, net | 12,047 |  |  | 1,470 |  |  | 13,517 |
Total liabilities | 322,165 |  |  | (9,977) |  |  | 312,188 |
Accumulated deficit | (620,033) |  |  | 9,977 |  |  | (610,056) |
Total stockholders’ equity | 37,814 |  |  | 9,977 |  |  | 47,791 |
| Condensed Consolidated Statements of Stockholders’ Equity
For the three months ended September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Accumulated deficit beginning balance | $ | (604,959) |  |  | $ | 2,068 |  |  | $ | (602,891) |
Total stockholders' equity beginning balance | 52,770 |  |  | 2,068 |  |  | 54,838 |
Net loss in both Accumulated Deficit and Total columns | (15,074) |  |  | 7,909 |  |  | (7,165) |
Accumulated deficit ending balance | (620,033) |  |  | 9,977 |  |  | (610,056) |
Total stockholders' equity ending balance | 37,814 |  |  | 9,977 |  |  | 47,791 |
| Condensed Consolidated Statements of Stockholders’ Equity
For the nine months ended September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Net loss in both Accumulated Deficit and Total columns | $ | (186,637) |  |  | $ | 9,977 |  |  | $ | (176,660) |
Accumulated deficit ending balance | (620,033) |  |  | 9,977 |  |  | (610,056) |
Total stockholders' equity ending balance | 37,814 |  |  | 9,977 |  |  | 47,791 |
| Condensed Consolidated Statements of Cash Flows
For the nine months ended September 30, 2023 | As Previously Reported |  | Adjustments |  | As Restated
Cash Flows From Operating Activities |  |  |  |  |
Net loss | $ | (186,637) |  |  | $ | 9,977 |  |  | $ | (176,660) |
Net loss from continuing operations | (186,786) |  |  | 9,977 |  |  | (176,809) |
Impairments | 155,864 |  |  | (9,232) |  |  | 146,632 |
Deferred income taxes | (13,191) |  |  | 1,470 |  |  | (11,721) |
Receivables, net | (3,884) |  |  | 11,447 |  |  | 7,563 |
Accrued agency fees and commissions | (4,386) |  |  | (2,215) |  |  | (6,601) |
Deferred revenues | (2,955) |  |  | (11,447) |  |  | (14,402) |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration